Lifevantage Corp (LFVN): Net Income
$5.07M
Year ended 2026-06-30
+25.9%
3-year compound annual growth
-17.0%
5-year compound annual growth
-1.8%
10-year compound annual growth
| Period ended | Net Income | Change YoY | Source filing |
|---|---|---|---|
| 2026-06-30 | $5.07M | -48.3% | 2026-08-27, From 2025-07-01 |
| 2025-06-30 | $9.80M | +233.8% | 2026-08-27, From 2024-07-01 |
| 2024-06-30 | $2.94M | +15.6% | 2025-09-04, From 2023-07-01 |
| 2023-06-30 | $2.54M | -18.6% | 2024-08-28, From 2022-07-01 |
| 2022-06-30 | $3.12M | -75.8% | 2023-08-28, From 2021-07-01 |
| 2021-06-30 | $12.89M | +11.6% | 2022-08-23, From 2020-07-01 |
| 2020-06-30 | $11.55M | +55.5% | 2022-08-23, From 2019-07-01 |
| 2019-06-30 | $7.43M | +29.0% | 2021-08-19, From 2018-07-01 |
| 2018-06-30 | $5.76M | +258.3% | 2020-08-18, From 2017-07-01 |
| 2017-06-30 | $1.61M | -73.7% | 2019-08-14, From 2016-07-01 |
| 2016-06-30 | $6.11M | -14.3% | 2018-08-15, From 2015-07-01 |
| 2015-06-30 | $7.12M | n/c | 2017-09-07, From 2014-07-01 |
| 2014-06-30 | $11.38M | +49.6% | 2016-12-12, From 2013-07-01 |
| 2013-06-30 | $7.61M | -39.0% | 2015-09-01, From 2012-07-01 |
| 2012-06-30 | $12.47M | n/m | 2014-09-10, From 2011-07-01 |
| 2011-06-30 | -$50.79M | n/a | 2013-09-12, From 2010-07-01 |
Net Income at similar companies
| Company | Year ended | Net Income | Change YoY |
|---|---|---|---|
| Lifevantage Corp (LFVN) | 2026-06-30 | $5.07M | -48.3% |
| Stoke Therapeutics, Inc. (STOK) | 2025-12-31 | -$6.88M | n/m |
| Maravai Lifesciences Holdings, Inc. (MRVI) | 2025-12-31 | -$130.77M | n/m |
| Cryoport, Inc. (CYRX) | 2025-12-31 | $78.30M | n/m |
| Rhythm Pharmaceuticals, Inc. (RYTM) | 2025-12-31 | -$196.54M | n/m |
| Phathom Pharmaceuticals, Inc. (PHAT) | 2025-12-31 | -$221.25M | n/m |
| Syndax Pharmaceuticals Inc (SNDX) | 2025-12-31 | -$285.42M | n/m |
| Liquidia Corp (LQDA) | 2025-12-31 | -$68.92M | n/m |
| Amarin Corp PLC (AMRN) | 2025-12-31 | -$38.80M | n/m |
Compare LFVN, STOK, MRVI, CYRX side by side · Screen every company in Pharmaceutical Preparations ↗